Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cancers|March 11, 2023
Is Segmental Ureterectomy Associated with Inferior Survival for Localized Upper-Tract Urothelial Carcinoma of the Ureter Compared to Radical Nephroureterectomy?Marco Paciotti, Khalid Y Alkhatib, David-Dan Nguyen, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 4, 2019
Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectivesSean W Berquist, Kendrick Yim, Stephen T Ryan, et al.
Minerva Urology and Nephrology|August 5, 2020
Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer: analysis of the National Cancer DatabaseStephen T Ryan, Devin N Patel, Fady Ghali, et al.
European Urology Oncology|July 24, 2023
Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Localized Kidney Cancer: Early Outcomes from a Prospective Phase 1 Trial and Supplemental CohortKendrick Yim, Shu-Hui Hsu, José Ignacio Nolazco, et al.
World Journal of Urology|March 14, 2018
Comparison of functional outcomes of robotic and open partial nephrectomy in patients with pre-existing chronic kidney disease: a multicenter studyZachary A Hamilton, Robert G Uzzo, Alessandro Larcher, et al.
Clinical Genitourinary Cancer|November 9, 2017
Renal Functional Outcome of Partial Nephrectomy for Complex R.E.N.A.L. Score Tumors With or Without Neoadjuvant Sunitinib: A Multicenter AnalysisMichelle L McDonald, Brian R Lane, Juan Jimenez, et al.
World Journal of Urology|February 3, 2019
Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomyZachary A Hamilton, Umberto Capitanio, Brian R Lane, et al.
Clinical Genitourinary Cancer|April 2, 2026
The Effect of Allogenic Blood Transfusion on Oncologic Outcomes in Locally Advanced Kidney CancerTaryn A Ellis, Cindy J Hernandez, Veerain Gupta, et al.
Urologic Oncology|September 10, 2023
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapyKendrick Yim, Kevin Melnick, Sarah L Mott, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Clinical and genomic profiling of early-onset bladder cancer identifies key alterations and therapeutic targetsChristopher J Magnani, Vincent D D'Andrea, Guilherme Garcia Barros, et al.
Pageof 3